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Abstract 
COVID-19 has caused unprecedented health, economic and societal impacts across the world, 
including many low- and middle-income countries (LMICs). The pandemic and its fallout have laid bare 
deep-seated social and economic inequalities with marginalised groups being at greater risk of 
infection and being disproportionately affected by containment measures and their socioeconomic 
consequences. Stigma is a central element to such inequalities but remains largely overlooked in the 
debate on the response to COVID-19, including in LMICs. Yet we know from experiences with other 
infectious diseases such as HIV/AIDS and Ebola that disease-related stigma is detrimental to halting 
and controlling pandemics and achieving equitable development. Emerging evidence suggests that 
stigma associated with COVID-19 is already taking hold. This paper assesses potential driving factors 
of COVID-19-related stigma, and how this intersects with existing stigma fault lines and explores 
mechanisms through which COVID-19-related stigma may be counteracted, with a focus on LMICs. 
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Since its onset, experiences with COVID-19 in China, Europe and the United States provide clear 
testimony of its far-reaching health, economic and societal impacts. It is becoming increasingly clear 
that the pandemic’s consequences are likely to be even graver in many low- and middle-income 
countries (LMICs). Higher transmissibility due to overcrowding in densely populated areas, larger 
household sizes and poor quality of water and sanitation, higher infection-to-case ratios due to high 
prevalence of comorbidities such as hypertension and diabetes, and higher fatality rates due to lack 
of health care capacity contribute to more severe health consequences in LMICs (Dahab et al. 2020). 
Lockdown measures and restrictions on movement that have been put in place to quell infection rates 
also have far-reaching adverse effects. Large proportions of the workforce in the informal labour 
market are left without any source of income and informal supply chains are disrupted (Kelley et al. 
2020). Estimates suggest that the number of people expected to fall into extreme poverty ranges 
anywhere between 80 million and 395 million (Sumner, Ortiz-Juarez, and Hoy 2020).  
To date (in June 2020), policy measures have focused on providing short-term economic relief for 
those most vulnerable (Gentilini et al. 2020) and on developing a vaccine that is available and 
affordable for all (Usher 2020). However, as experiences with HIV/AIDS, Ebola, cholera and other 
transmissible diseases have highlighted, responses to pandemics often suffer from a narrow 
biomedical focus and overlook the social, economic, political and cultural contexts in which they take 
place (Kelley et al. 2020). This limits understandings of how disease might spread, who is affected and 
how, and how policies should be shaped to offer the most effective and equitable response. This is no 
different for COVID-19: the sheer scale of the pandemic, the speed at which it has spread and the 
urgency with which response measures are being put in place means that socioeconomic dynamics 
and inequities receive relatively little attention (Kelley et al. 2020). Moreover, LMICs’ replication of 
policies that originate from high-income countries call into question the extent to which such policies 
are adequately contextualised and pay attention to existing patterns of socioeconomic injustice 
(Barnett-Howell and Mobarak 2020; SSHAP 2020).   
Stigma is integral to patterns of injustice, and experiences with other pandemics highlight that paying 
heed to stigma is vital for providing an effective and equitable response to COVID-19. Long-standing 
research on HIV (Mahajan et al. 2008; Castro and Farmer 2005) and neglected tropical diseases (NTDs) 
(Hofstraat and van Brakel 2016) as well as more recent experiences with Ebola (Karamouzian and 
Hategekimana 2014) indicate that stigma is experienced by those being affected by disease or by 
groups that may be seen as ‘vehicles’ for, or most structurally vulnerable to, infection. Stigma also 
intensifies along fault lines such as class, age, gender and race (Lerman, Ostrach, and Singer 2017). 
Stigma is detrimental to halting and controlling pandemics and achieving equitable development. It 
puts up barriers to accessing health care and social services, impedes health-seeking behaviour, 
undermines adherence to treatment and  leads to social exclusion, discrimination, mental distress and 
– in some cases – violence (Rohrwerder 2018; Stangl et al. 2019; Author A 2019). Although COVID-19 
is still relatively new, the many unknowns and uncertainties associated with this ‘newness’ may give 
rise to fear that can in turn fuel stereotyping and stigmatisation (UNICEF 2020). Indeed, stigmatisation 
of those infected with the virus is already mounting (United Nations 2020a). 
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The objective of this paper is two-fold. First, we assess potential driving factors of COVID-19-related 
stigma, and how this intersects with existing stigma fault lines. Second, we explore mechanisms 
through which COVID-19-related stigma may be counteracted and prevented. We do so by taking an 
interdisciplinary approach and building on well-established research on disease-related stigma in 
relation to pandemics such as HIV, NTDs and Ebola as well as literature on stigma associated with old 
age, disability and poverty. We find that driving factors of COVID-19-related stigma are already taking 
shape and stigma experiences are manifesting themselves. We call for a rights-based and inclusive 
response to COVID-19 that maximises equitable health outcomes and minimises the risk of COVID-19-
related stigma in LMICs. 
The remainder of this article is structured as follows: First, we provide a conceptual framework to 
underpin our analysis of COVID-19-related stigma. Second, we assess driving factors that contribute 
to COVID-19-related stigma. Third, we explore fault lines that intersect with and compound COVID-
19-related stigma. Fourth, we explore ways in which such stigma may be avoided in the response to 
COVID-19. Finally, we offer critical reflections for future action. 
2. Framing stigma  
In his seminal work on stigma, Goffman (1963) posits that stigma denotes an attribute that is 
discreditable, leading to a ‘spoiled identity’. Stigma represents a characteristic that is different from 
‘normal’ and triggers disapproval or devaluation in certain social contexts (Bos et al. 2013; Link and 
Phelan 2001) with those being stigmatised somehow deemed to be less human (Goffman 1963). 
Stigmatisation constitutes others’ responses to stigma and can be overt, such as avoidance and 
humiliation, as well as more subtle, including lack of eye contact (Bos et al. 2013). This, in turn, 
interacts with ‘potential internalization of the negative beliefs and feelings associated with the 
stigmatised condition’ (Bos et al. 2013), understood as self-stigma, internalised stigma or shame. One 
can also distinguish between ‘existential’ and ‘achieved’ stigma (Falk 2001). Existential stigma derives 
from a condition that is mostly outside of the control of the target of the stigma, while achieved stigma 
applies to those ‘who have earned a stigma because of their conduct and/or because they contributed 
heavily to attaining that stigma’ (11). 
Stigma has far-reaching intrapersonal, interpersonal and societal consequences, ultimately 
undermining efforts to counteract pandemics and promote equitable development. It leads to social 
isolation, hampers access to care, and reduces treatment adherence (Muela Ribera et al. 2009). During 
the Ebola pandemic in western Africa from 2014 to 2016, Ebola patients, survivors and orphans (and 
on occasion their relatives), as well as health workers involved in the response faced “shunning and 
isolation, ill-treatment, [and] the rejection of treatment and political or economic exclusion” (ERAP 
2014: 1). Fear of stigma led Ebola-affected families to hide symptoms from their communities and 
health services (Hewlett and Hewlett 2008). Similar reports emerged from survivors and health 
workers as a result of the SARS pandemic in some Asian countries (Lee et al. 2005; Verma et al. 2004). 
There is also published evidence of widespread stigma related to NTDs such as lymphatic filariasis, 
podoconiosis, Buruli ulcer, onchocerciasis, leprosy, and leishmaniasis (Hofstraat et al 2016: 65).  
These examples of disease-related stigma can be linked to Goffman’s notion of ‘spoiled identity’. A 
common critique of Goffman’s theory, however, is that it provides an apolitical understanding of 
stigma, placing the onus of being ‘discredited’ on those that are stigmatised. Instead, as pointed out 
by scholars across the health and social sciences, stigma takes hold and is perpetuated within a social 
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context with inherent power structures, serving to put in place and maintain hierarchies and social 
order (Link and Phelan 2001; Tyler and Slater 2018; Parker and Aggleton 2003). Building on 
conceptualisation of stigma within the field of HIV (Earnshaw et al. 2013), COVID-19-related stigma 
can be understood as a social phenomenon whereby people infected with or affected by COVID-19 
are labelled, stereotyped or discriminated against and that intersects with existing fault lines of 
socioeconomic disadvantage, thereby perpetuating and reinforcing power structures and structural 
inequalities. Stigma is the visible ‘tip of the iceberg’ of much wider systems of beliefs about who carries 
disease and why that are grounded in and compounding social inequalities (Castro and Farmer 2005). 
The Health Stigma and Discrimination Framework by Stangl et al (2019) helps to ground 
understandings of stigma within a wider context and to map the process from drivers and facilitators 
of stigma through to outcomes of stigma. Drivers of stigma tend to be specific to the health condition, 
including fear of infection, lack of awareness, stereotypes and prejudice. Facilitators of stigma apply 
more broadly and include social and cultural norms, levels of inequality and legal and policy 
environments. The health-related stigma itself intersects with other stigma ‘markers’ such as age, 
gender, race and class. This then leads to experiences, manifestations and outcomes at individual, 
societal and institutional levels, ranging from internalisation of stigma to social exclusion and 
institutionalised discrimination (Stangl et al. 2019).  
The framework’s multi-layered focus and the way in which it locates the process of stigmatisation 
within the wider socioeconomic context makes it particularly useful for coming to grips with the 
unfolding and evolving nature of COVID-19-related stigma in LMICs. It affords an opportunity to move 
away from biomedical explanations of how the pandemic may evolve and provides a biosocial 
perspective. Experiences in relation to HIV and AIDS have evidenced the importance of understanding 
social, economic and political processes surrounding disease in order to create an effective response 
(Castro and Farmer 2005). Given the evolving nature of the pandemic and its drivers, dynamics and 
manifestations, we zoom in on emergent driving factors of COVID-19-related stigma and fault lines 
along which existent stigma may be reproduced and compounded.  
3. Driving factors of COVID-19-related stigma 
Based on a review of in relation to other transmissible diseases, attributes such as old age, disability 
and poverty and unfolding knowledge about COVID-19-related stigma, we identify three interrelated 
driving factors.  
3.1. Lack of information and misconceptions 
First, lack of information, misinformation and misconceptions serve as key conduits for stigma, often 
assigning blame for disease. Whilst biomedical explanations may be widely available, alternative 
explanations or misinformation may emerge with specific individuals being singled out as causes or 
carriers of disease, playing into ‘achieved’ stigma. For example, during previous Ebola outbreaks in the 
Democratic Republic of Congo (DRC), the disease had been attributed to witchcraft or sorcery, 
supposedly enacted by those who were perceived to ‘benefit’ from a patient’s death, widows or 
mothers of the disease, or people who are seen as outcast and in contact with non-natural forces 
(Ripoll et al. 2018). In Pakistan, the general public incorrectly identified dementia symptoms as a 
normal part of aging, or perhaps more concerning, that it is attributable to the actions of the 
individual. The latter inevitably led to people believing that the person with dementia should be 
responsible for their own healthcare and outcomes (Author C 2019). Similar dynamics have been 
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observed in relation to disability with cultural and religious beliefs playing into false perceptions about 
causes of disability (Rohrwerder 2018). Across Africa, stigma-inducing beliefs include disability being 
caused by ancestral curses or transgressions in previous generations, demonic possession and 
supernatural or otherworldly interference, promiscuity or other sinful behaviour by the mother or 
other family member or a punishment for wrongdoing by the person with a disability (ibid). Stigma 
may also arise from beliefs that people with a certain condition pose a burden to society. These 
experiences are clearly visible in relation to disability with low (and often misplaced) expectations 
about how people with disabilities can or cannot contribute to society leaving them labelled as less 
able or productive (Rohrwerder 2018). 
Misinformation and misconceptions in relation to COVID-19 are already widespread. There are still 
many unknowns about the virus (UNICEF 2020), offering fertile feeding ground for misconceptions 
and alternative explanations. Internet and social media are widely used to obtain information about 
COVID-19 but often information is of low quality (Cuan-Baltazar et al. 2020). The WHO has referred to 
an ‘infodemic’ to denote the excessive volume of information that is available, much of which is 
incorrect (Erku et al. 2020). There is some suggestion that the spread of misinformation may be larger 
in LMICs (Wajahat Hussain 2020), possibly due to greater reliance on social media for information and 
lower capacity for fact-checking. BBC News Africa has launched a COVID-19 misinformation hub, 
offering a service that fact-checks and debunks false information about the pandemic (BBC News 
Africa 2020).  
3.2. Fear of contagion 
Second, fear of contagion is a significant driver of prejudice, stereotyping and stigmatising behaviour. 
This has been widely observed as in relation to disability (Rohrwerder 2018) and NTDs (Hofstraat and 
van Brakel 2016). Widespread anxiety about the cause and spread of SARS constituted an important 
mechanism for stigma to take hold at the time of the outbreak in Asia in the early 2000s (Person et al. 
2004). In China, fear of contracting HIV was an important source of stigmatising attitudes associated 
with HIV and AIDS among rural-urban migrants (Hong et al. 2008). This also relates to ‘existential’ and 
‘achieved stigma’; disease-related stigma is often related to the extent to which the person being 
stigmatized is deemed at fault for having contracted the illness if their behaviour contributed to 
infection. Such ‘victim-blaming’ has been widely observed in relation to HIV and AIDS, including in the 
Caribbean (Castro and Farmer 2005). 
The infectious nature of COVID-19 and its potentially life-threatening consequences coupled with 
ubiquitous updates about infection and fatality rates leads to high levels of anxiety, stoking fear of 
infection (Basu 2020). Already examples are emerging of how such fear leads to prejudice, avoidance 
and demonisation. In Ecuador, the family of the first person having contracted the virus fell victim to 
a harsh social media campaign, accusing them of irresponsible behaviour (Armario 2020). In Indonesia, 
names of the first few cases were leaked online, with one woman being falsely blamed for having 
contracted the virus due to selling sex to a foreign client (ibid). In Kenya, a survivor of COVID-19 
reported to be shunned by the community after having returned from hospital for fear of him infecting 
others (Soi 2020). In Bangladesh and India, social shunning of those (suspected of) being infected with 
COVID-19 reportedly led to suicide (Mamun and Griffiths 2020).  
3.3. Targeted policies 
7 
 
Third, policies that single out and separate vulnerable groups and the narratives that underpin them 
often inadvertently act as conduits for stigma. Such policies are the most visible way of labelling those 
who are ‘deviant’ and distinguishing them from the rest of society who are deemed ‘normal’, laying 
the foundation for legitimisation and institutionalisation of stigma (Falk 2001). The cholera response 
in Brazil, for example, unwittingly ‘earmarked’ specific communities or persons as foci of disease 
transmission through their targeting, treatment and risk communications strategy (Nations and 
Monte 1996). In relation to disability, there is a long history of segregating people with disabilities 
from the rest of society by placing them in institutions, leading to perpetuation of negative 
stereotypes (Rohrwerder 2018). With respect to old age, there are stereotypes that older adults are 
weak and need help (Coudin and Alexopoulos 2010), feeding into a notion that elderly persons 
represent a burden to society. 
Many policies that seek to contain the spread of COVID-19 rely strongly on practices of singling out, 
separating and labelling, thereby laying the foundation for stigma. Quarantine, a measure that has 
also been used in Ebola and SARS outbreaks, is likely to feed COVID-19-related stigma (Brooks et al. 
2020). In India, air crew staff felt stigmatised after health authorities stamped ‘quarantined’ on their 
houses (Krishnatray 2020). Gender-based physical distancing measures may also bring to the light 
people’s sexual orientation or non-conforming gender identities, putting them at risk of harassment 
and prejudice. In Colombia, measures to limit the number of people on the streets allowed men and 
women to go outdoors for essential tasks on alternate days, leaving trans people at risk. Multiple 
reports of abuse and violence against trans people were reported (Griffin and Antara Rivera 2020).  
4. Fault lines for COVID-19-related stigma 
Disease-related stigma does not stand on its own and in fact interacts with other fault lines, layering 
onto already existing processes of discrimination and marginalisation and leading to intersecting or 
co-stigmas. For example, when cholera re-emerged in Latin America in the 1990s, the disease was 
attributed to poor people, who had been previously neglected and marginalised by the state in terms 
of provision of basic water and sanitation infrastructure and health services. Cholera was also 
racialised, and poor black and indigenous people were ‘othered’ as dirty or filthy (Briggs and Mantini-
Briggs 2003; Nations and Monte 1996). Those living in informal settlements were unable to implement 
the government guidelines on cholera, because of inadequate infrastructure (e.g. water points and 
soap) (Ripoll 2017). In China, HIV/AIDS-related stigma was found to co-exist and interact with 
commonly associated stigma attached to injection drug use and commercial sex (Chan et al. 2007). 
Across LMICs, we can also see such fault lines emerging that make certain groups more vulnerable to 
COVID-19-related stigma. We identify four main fault lines. 
4.1. Poverty and informality 
First, people living in poverty, precarious conditions or informal settlements are at a heightened risk 
of COVID-19-related stigma. Poverty and deprivation itself is a potent trigger for stigma, leading to 
internalisation of stigma and shame (Walker 2014). This in combination with the many difficulties that 
people in poverty and precarious conditions face in adhering to distancing measures provides a potent 
mix for stigma. Guidelines on hand hygiene, physical distancing or lockdown are often not plausible in 
densely populated, informal and impoverished contexts due to crowding, insufficient water and 
sanitation services and low and precarious incomes (Wilkinson 2020). Similarly, farm workers, 
refugees and people living on the street are both less able to adhere to lockdown and physical 
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distancing measures while also more affected by those measures (Devereux et al. 2020). This makes 
them vulnerable to negative stereotyping and being labelled as vehicles of infection, which 
compounds stigma that pre-dates COVID-19 (Logie and Turan 2020).  
4.2. Ethnicity, origin and nationality 
Second, ethnicity and nationality represent important fault lines for COVID-19-related stigma. Blaming 
a ‘foreign other’ for the outbreak of disease is commonplace in order to make sense of and distance 
oneself from disease (Logie and Turan 2020). For example, during the 2018 Ebola outbreak in DRC, the 
Twa indigenous group was singled out by the majority Bantu community as transmitters of the disease, 
and experienced discrimination in their access to health services (Duda, Alcayna-Stevens, and Bedford 
2018). Stigmatisation of Asians, or anyone deemed of Asian origin, was widespread in North America 
and Europe in relation to SARS and Avian Flu (Lynteris 2019; Rafi 2020; Person et al. 2004).  
Similar co-stigma is likely to occur in relation to COVID-19. The fact that the virus first emerged in 
China has given rise to negative attitudes, discrimination and xenophobia directed at Chinese people 
or those who are perceived to be of Asian descent in many high-income countries, such as Canada 
(NCCDH 2020). Few reports of Sinophobia have emerged from across LMICs, although experiences 
involving Chinese nationals in Uganda indicate that mistrust based on assumed nationality and origin 
is on the rise (Oryem 2020). Instead, a more disparate group of people ‘on the move’ have been 
stigmatised for spreading the virus. Depending on who and where these groups are, this may be 
associated with ethnicity, nationality or place of origin (United Nations 2020a). In Mozambique, for 
example, mine workers who migrated back home from South Africa were met with suspicion when 
integrating back into their communities (UN Department of Global Communications 2020). Finally, 
with a growing evidence base now indicating that Black, Asian and Hispanic patients are at a higher 
risk of contracting COVID-19 (Pan et al. n.d.), ethnic minority is further compounded as a co-stigma. 
4.3. Age 
Third, age – and old age in particular – is likely to emerge as fault line for COVID-19-related stigma. 
Deaths associated with COVID-19, disproportionately occur in older adults (Jordan, Adab, and Cheng 
2020; Zhou et al. 2020). This can be attributed to older adults having increased likelihood of underlying 
health conditions such as diabetes and cardiovascular disease (Suastika et al. 2012), hypertension 
(Buford 2016), and respiratory problems (Buist et al. 2007), all of which increase the risk of COVID-19-
related deaths (Wu and McGoogan 2020; Zhou et al. 2020). In addition, ageing results in a general 
decline in immune responses (Weiskopf, Weinberger, and Grubeck‐Loebenstein 2009), making older 
adults more vulnerable to such viruses. As such, it is unsurprising that many health policies are put in 
place to protect this group. 
However, this focus on old age as a factor of vulnerability is likely to compound existing patterns of 
ageism. In Kenya, ageism has led to the marginalisation, loss of power and dignity of older adults, 
opening the way to elder abuse (Kabole, Kioli, and Onkware 2013).  Within LMICs more broadly, older 
adults describe that they are being denied autonomy related to finances, work, family life and their 
everyday activities (HelpAge International 2018). Governments may not have the healthcare and 
support systems in place to support older adults, further restricting older adults’ choices. This in itself 
may reflect structural discrimination, as age limits imposed by global health policy and targets may 
lead to governments not allocating health resources to older adults (Lloyd-Sherlock et al. 2016).  
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4.4. Gender and sexualities 
Fourth, gender and sexualities are emerging as important fault lines for COVID-19-related stigma. In 
many countries, LGBTI people have previously been blamed for disasters or disease. In Bhutan, for 
example, transgender women were held responsible for natural disasters (Chuki 2019). In Zimbabwe, 
LGBTI people affected by HIV and AIDS were blamed for their illness and for placing a curse on their 
family (Hunt et al. 2017). Reports are already emerging of such blaming taking place in relation to 
COVID-19, such as in Israel where one Rabbi propagated coronavirus as the revenge to gay parades 
and in Iran where a Shia cleric warned that the pandemic would not subside as long as same-sex 
marriages were legal in Iran (United Nations 2020b). The United Nations has also highlighted that 
surveillance and control of populations in order to contain the virus can galvanise oppression of sexual 
and gender minority peoples (United Nations 2020a), often in settings where transphobic and 
homophobic actions are already prevalent. In Uganda, for example, police reportedly used laws that 
prohibited more than 10 people gathering in public to arrest 23 people living in a sheltered housing 
project for LGBTI people (United Nations 2020b).  
5. Countering stigma 
There is a wide and well-established body of literature that assesses the role and effectiveness of 
interventions to counter disease-related stigma. These interventions engage at the intrapersonal level 
– seeking to counter internalised stigma – as well as at interpersonal and community level. With 
respect to NTDs, these commonly include self-care and self-help (Pryce et al. 2018), educational 
programmes (Correia et al. 2019), assistive technology (Maia et al. 2016), and community engagement 
approaches (Jung et al. 2020). Other measures against stigmatisation tend to be health education for 
patients and the community (Zeldenryk et al. 2011) and disease management, yet the effectiveness 
of these measures has not been demonstrated in the literature (Hofstraat and van Brakel 2016). 
Additional measures include rehabilitation, counselling and support groups (ibid).  
Most of these measures can be considered reactive, aiming to counteract or reduce already existing 
patterns of stigma. Moreover, they are predominantly premised on a biomedical approach and are 
therefore highly individualistic, aiming for empowerment on a top-down basis that is largely 
disconnected from the structures that facilitate and legitimise stigma in the first place (Scambler 
2009). With COVID-19 still evolving and its longer-term responses beginning to take shape, a more 
proactive and strategic approach to avoid stigma taking hold at a large scale may be more equitable 
and effective. Adverse unintended social consequences are to be avoided  (Hargreaves et al. 2020) 
rather than to be grappled with once they have taken hold. Crucially, any policy response needs to 
acknowledge and address the human rights violations that caused COVID-19 to flourish in the first 
place, and new violations that have resulted from the disease that allow stigma to reproduce itself 
and new stigmas to emerge. Without addressing the root causes of violations, the next disease or the 
next pandemic will repeat the stigma cycle where certain violations cause disease and new violations 
are created due to disease.  
Experiences in relation to other disease-related stigma, including NTDs and HIV, points to the 
importance of a rights-based and inclusive response. Public health programmes that take a rights-
based approach have been shown to ‘improve service delivery and enhance equality, equity, 
inclusiveness, and accountability’ (Sun and Amon 2018). The WHO has set out a rights-based approach 
to NTDs, and that could apply to COVID-19 and other transmissible diseases, which emphasises the 
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principles of participation, non-discrimination, and accountability (WHO  2009). This resonates with a 
recently published report by the United Nations that places human rights at the centre of the response 
to COVID-19 and recommends, among others, that policies should guarantee meaningful participation 
of all sectors of society, that efforts need to reach those most vulnerable and traditionally 
marginalised, that political leaders and other actors should speak out against discrimination and that 
freedom of expression is guaranteed in order to hold governments to account (United Nations 2020a). 
We discuss key considerations for a rights-based and inclusive approach to avoiding and mitigating 
COVID-19-related stigma within the context of LMICs. 
5.1. Participation and inclusion 
Participation and engagement of those affected by COVID-19 will be vital for ensuring that responses 
are contextualised, localised and responsive to needs (Logie and Turan 2020). In order to avoid that 
social and economic inequalities are overlooked or compounded, participation needs to cut across 
intersecting stigmas and fault lines (ibid) such as poverty, ethnicity and age (Hargreaves et al. 2020). 
Depending on the disease and the context, working with communities and those affected by disease 
will allow for tailored and community-led responses. For example, the Twa in DRC were incorporated 
into the response to deliver their own services, and communication materials were prepared in the 
local language (Duda, Alcayna-Stevens, and Bedford 2018). In Liberia, the inclusion of Ebola survivors 
is recommended for developing interventions for Ebola-related stigma (Overholt et al. 2018).  
In addition, states have an obligation to ensure that laws, policies, and the distribution and delivery of 
resources, health services, and underlying determinants of health adhere to the principles of equality 
and non-discrimination. For example, in Sierra Leone, one of the initiatives promoted by the Ebola 
Response Anthropology Platform was a step-by-step reintegration process in which a social contract 
was signed by the community and the survivor, including the negative results of the tests, the 
commitment to pursue infection control practices, and the willingness to welcome the individual 
(ERAP 2014).  
Inclusion should not be taken at face value. Experiences with the response to HIV are instructive in 
this respect. Inclusive actions, and their associated forms of knowledge about HIV, have themselves 
often been subject to stigma (Parker and Aggleton 2003). Indeed, still today gender and sexual 
minority peoples continue to be failed by the international HIV and AIDS response, even as it bears 
the imprint of sexualities activism. Inclusion may look like it is happening when ‘LGBT recognition’ is 
inserted into policy documents and programme guidelines, but substantive and on-the-ground action 
is called for, based in the lived realities of people of diverse gender and sexuality (Author B 2019). 
Inclusion may also be at odds with preventing stigma. Focusing efforts on the inclusion of vulnerable 
and traditionally marginalised groups requires identification and targeting of such groups. Targeted 
service delivery inevitably requires labelling and separating out, which in itself is a source of 
stigmatisation. Service provision premised on the principle of universalism may be powerful in 
preventing stigma (Author A 2019). In the case of cholera in Brazil, for example, affected poor 
communities felt less stigmatised when the target of hygiene promotion activities and communication 
was universal (rather than specific to the poor communities), and when treatment was given as part 
of broader services for diarrheal disease or broader health system reinforcement, rather than 
stigmatising cholera treatment centres (Nations and Monte 1996). At the same time it should be noted 
that ‘shared stigma’ can also galvanise positive action within affected groups (Van Laar, Derks, and 
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Ellemers 2013), making them agents of change in a way that may not have happened without stigma 
serving as a binding factor. 
The very nature of COVID-19 also poses challenges to a truly inclusive approach. With many of the 
containment measures focused on physical distancing, the potential for groups to have contact and 
learn from each other is inevitably hampered. This poses a real conundrum in terms of trying to avoid 
stigma (Logie and Turan 2020). In line with experiences with SARS, balancing the protection of public 
health while preventing stigmatisation of groups that are greater risk of contracting or spreading the 
disease during a rapidly evolving pandemic like COVID-19 is fraught with complexities (Person et al. 
2004).  Experiences with Ebola in Liberia suggest that minimising social isolation, reintegration in 
recognition of the end of transmission risk and community-wide economic support serve as pre-
emptive approaches for mitigating long-term stigma (Overholt et al. 2018).  
5.2. Language and labelling 
Careful use of language is also to a non-discriminatory and inclusive approach.  Analogies between 
disease and war by referring to being ‘invaded’, to having to ‘fight’ the virus or having to win the 
‘battle’ feed anxiety and fear of contagion (Logie and Turan 2020) that in turn play into stigma. 
Common use of the word “vulnerable” could reinforce existing stereotypes of weakness and 
helplessness, particularly in relation to old age (Nifosi-Sutton 2017). Experiences with NTDs are also 
instructive in terms of how language can contribute to discriminatory discourse. With the term NTDs 
spanning almost forty diverse diseases, the words ‘neglected’ and ‘tropical’ provide little 
understanding of the diseases and their health impacts. Instead, they point to a socially constructed 
category that is reflective of environmental determinism and denial of systematic marginalisation that 
have allowed these diseases to persist (Shahvisi 2019). Thus, the term and category ‘Neglected 
Tropical Disease’ is itself stigmatising, with those suffering from NTDs have been ‘cast off’ and often 
experiencing isolation, discrimination, and prejudice in their own communities. These lessons are 
instructive in terms of language used to categorise flu-like (such as COVID-19) diseases as Asian, and 
how it gives rise to accompanying discriminatory language that borders on hate-speech. While WHO 
introduced guidelines in 2015 to halt the naming of diseases in relation to their origin, this does not 
prevent the association of diseases with their place of origin from popular discourse with politicians 
and media being common culprits, as is the case for COVID-19 (Nature 2020). 
5.3. Transparency and accountability 
It follows that governments and decision makers need to be transparent about the processes and 
actions that underlie their policy and legal choices. Monitoring and adequate reporting of policies, 
laws and legal cases is integral to the rights-based approach, also referred to as ‘policy surveillance’ 
(Amon 2014). Policy surveillance can provide an analytical tool to assess prevalence and trends, and 
‘can facilitate the evaluation of health laws, health rights, and accountability mechanisms’ (ibid). 
Rights-based approaches have diverse meanings and are subject to different interpretations, 
depending on the actors involved (Miller 2010). It is therefore important to consider and make explicit 
the differing agendas that different actors might have. Doing so lays the foundation for the agreement 
that ‘duty-bearers’ meet their obligations and ‘rights holders’ claim their rights (WHO 2009) according 
to (1) the availability of facilities, good and services, (2) accessibility based on non-discrimination, 
physical, economic, and information accessibility, (3) acceptability in regards to medical ethics, 
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culture, and sensitivities to age and gender, (4) quality of services and care both scientifically and 
medically (ibid). 
Bringing the issue of stigma front and centre is crucial to ensure transparent and accountable policy 
design and implementation. Disease elimination criteria often stipulate that programs ‘count’ disease 
burden and morbidity to claim success, while issues like stigma are less tangible and more difficult to 
address. However, given the early onset and persistence of stigma, seeking to prevent and minimise 
it during and after disease outbreaks is paramount (Overholt et al. 2018). Doing so necessitates the 
inclusion of measures to assess and evaluate reductions in stigma. Although the measurement of 
stigma is complex, the scientific understanding of stigma depends on our capacity to observe and 
measure it  (Link et al. 2004). In a review of health-related stigma (Van Brakel 2006) identified five 
common approaches to measurement, ranging from surveys of attitudes towards those with certain 
health conditions to interviews with those affected by such health conditions. These tools ought to be 
located in specific structural and cultural relations to facilitate the important distinction between the 
consequences of health-related stigma and a cross-cultural theory of health related-stigma (ibid).  For 
example, stigma experiences and practices associated with HIV and NTDs might manifest similarly, yet 
they are products of entirely different structural drivers and facilitators (Scambler 2009). This 
exemplifies the need for a biosocial perspective of COVID-19-related stigma, locating it within wider 
structural and institutional systems as opposed to narrowing understandings to what happens at intra- 
and interpersonal levels (Logie and Turan 2020). 
Pressure towards continued focus and attention can come from communities themselves and, in part, 
stigma can serve as an important catalyst for doing so. As noted above, affected groups can be come 
agents of change with stigma serving as a catalyst. What we have learned from HIV activism over many 
years is that struggles are on-going; they require enduring attention, often beyond the mantras of 
inclusive policy actions or anti-stigma frameworks in the international community. Better conceiving 
stigma can provide a model of addressing such concerns, helping to promote meaningful health 
promotion action in terms informed by understandings of the relation between lived experience, 
structural vulnerabilities and (scientific) knowledge communities. Crises typically entail the coming 
together of experts in attempts to define and resolve a problem to hand – such as a virus and its 
associated social, political economic effects. What we advocate for here is a conscious broadening of 
expertise, to include sociological and other experiential knowledge about stigma as it informs life-
worlds of inequality within which COVID-19 is intrinsically interconnected. 
6. Conclusion  
It is widely acknowledged that stigma negatively impacts health practices and outcomes, reinforces 
structural inequalities and undermines equitable development. Emerging evidence suggests that 
stigma associated with COVID-19 is already taking hold. Against this backdrop, this article aimed to 
assess the driving factors and markers of COVID-19-related stigma and to reflect on how the response 
to COVID-19 can counteract such stigma in LMICs. We did so by drawing on lessons learned from other 
disease-related stigma and stigma markers such as old age, disability and poverty in LMICs.  
We find that COVID-19-related stigma is already taking hold across LMICs. Rapid spread of 
misinformation fuels misconceptions and false beliefs about how the virus spreads and who may be 
‘carriers’ of disease. This in turn feeds already strong fears of contagion, offering further fertile ground 
for stigmatisation of those who have been or are suspected of being infected by the disease or risk 
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infecting others. These dynamics are further reinforced by efforts to contain the virus that hinge on 
separating and isolating vulnerable groups and infected individuals. Poverty, precarious and unstable 
living conditions, ethnicity and origin, age and gender present fault lines along which stigma is 
compounded and reinforced.  
A rights-based and inclusive approach to policy that includes the principles of participation, non-
discrimination, and accountability is vital.  COVID-19 policy and health programmes need to focus on 
disease elimination or transmission interruption, but they must also ‘count what counts’ through 
research into stigma and intersecting vulnerabilities, as well as the conditions which produced the 
stigma in the first place. Accounting for and monitoring the interplay between factors at the inter- and 
intrapersonal, institutional and structural levels is vital for moving beyond a top-down and 
individualistic approach. Before stigma policy and programmes can be implemented, we must explore 
what rights violations have contributed to COVID-19 stigma and what new violations have emerged 
due to COVID-19 stigma.  
In sum, COVID-19-related stigma in LMICs is a real force to be reckoned with. Not only does it 
undermine basic levels of dignity, it also causes new types of vulnerabilities, reinforces pre-existing 
inequalities and ultimately poses a threat to effective containment of COVID-19. In order to be 
equitable and effective, the response to COVID-19 in LMICs requires the issue of stigma to be placed 
front and centre to its approach.  
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